Application of DNA-based forensic analysis for the detection of homologous transfusion of whole blood and of red blood cell concentrates in doping control
Gellmans company Longevity Biotech now has a drug candidate that activates both GLP-1 and GIP, is biased towards the insulin signalling pathway and can be orally formulated
Gallbladder issues, including gallstones, may occur, especially during rapid weight loss
Three regulators, no clear owner When a patient sees a Medvi ad on social media, clicks through, fills out an intake form, is prescribed a compounded GLP-1 by a physician theyve never met and receives medicine from a pharmacy, at least three federal regulatory agencies oversee that interaction, plus the relevant state medical board and possibly the FTCs digital advertising division
An emerging role for neutrophil extracellular traps in noninfectious disease
According to KFF health data, one in eight Americans have already tried a type of GLP-1 drug, and that number is expected to grow exponentially over the next decade
